Royalty Pharma to present at upcoming investor conferences

Rhea-AI Summary

Royalty Pharma (Nasdaq: RPRX) will present at two investor conferences in May 2026: BofA Securities Healthcare Conference on May 13, 2026 at 1:40 p.m. ET and RBC Capital Markets Global Healthcare Conference on May 19, 2026 at 10:00 a.m. ET.

Webcasts are available from the company’s Events page and will be archived for a minimum of 30 days.

AI-generated analysis. Not financial advice.

News Market Reaction – RPRX

+1.18%

1 alert

+1.18% News Effect

On the day this news was published, RPRX gained 1.18%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

NEW YORK, May 07, 2026 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in the following upcoming investor conferences during the month of May:

• BofA Securities 2026 Healthcare Conference on Wednesday, May 13 at 1:40 p.m. ET / 10:40 a.m. PT
• RBC Capital Markets 2026 Global Healthcare Conference on Tuesday, May 19 at 10:00 a.m. ET

The webcasts will be accessible from Royalty Pharma’s “Events” page at https://www.royaltypharma.com/investors/events/. Webcasts will also be archived for a minimum of thirty days.

About Royalty Pharma plc

Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to leading global pharmaceutical companies. Royalty Pharma has assembled a portfolio of royalties which entitles it to payments based directly on the top-line sales of many of the industry’s leading therapies. Royalty Pharma funds innovation in the biopharmaceutical industry both directly and indirectly – directly when it partners with companies to co fund late-stage clinical trials and new product launches in exchange for future royalties, and indirectly when it acquires existing royalties from the original innovators. Royalty Pharma’s current portfolio includes royalties on more than 35 commercial products, including Vertex’s Trikafta and Alyftrek, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya, Biogen’s Tysabri and Spinraza, Servier’s Voranigo, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, Pfizer’s Nurtec ODT, and Gilead’s Trodelvy, and 19 development-stage product candidates. For more information, visit www.royaltypharma.com.

Royalty Pharma Investor Relations and Communications

+1 (212) 883-6772
ir@royaltypharma.com

FAQ

When will Royalty Pharma (RPRX) present at the BofA Securities 2026 Healthcare Conference?

Royalty Pharma will present on May 13, 2026 at 1:40 p.m. ET. According to Royalty Pharma, the presentation will be webcast from the company Events page and archived for at least 30 days for later viewing by investors.

What time is the Royalty Pharma (RPRX) presentation at the RBC Capital Markets 2026 Global Healthcare Conference?

Royalty Pharma is scheduled for May 19, 2026 at 10:00 a.m. ET. According to Royalty Pharma, the session will be webcast via the company Events page and the archive will remain available for a minimum of thirty days.

Where can investors watch the Royalty Pharma (RPRX) conference webcasts?

Investors can watch via the company’s Events page at royaltypharma.com/investors/events. According to Royalty Pharma, live webcasts will be posted there and archived for at least 30 days for on-demand access.

Will Royalty Pharma (RPRX) archive the May 2026 conference webcasts and for how long?

Yes; webcasts will be archived for a minimum of 30 days. According to Royalty Pharma, recordings of the May 13 and May 19 presentations will remain accessible on the Events page for at least thirty days after posting.

Do investors need to register to view Royalty Pharma (RPRX) webcasts for the May 2026 conferences?

The company’s notice does not specify registration requirements. According to Royalty Pharma, webcasts will be accessible from the Events page, and archived recordings will be posted for at least 30 days for investor access.

How can shareholders prepare to follow Royalty Pharma (RPRX) presentations on May 13 and May 19, 2026?

Bookmark the company Events page and plan to join at the scheduled times. According to Royalty Pharma, live webcasts will stream on the Events page and recordings will be archived for a minimum of thirty days for later review.